Chiba, Japan

Nobuo Sakamoto

This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nobuo Sakamoto. Retrieved from https://idiyas.com/inventor/nobuo-sakamoto-xgm5cpin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nobuo Sakamoto: Innovator in Medical Science

Introduction: Nobuo Sakamoto is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of medicine, particularly in the development of agents that address serious health conditions. His work has led to the creation of a patent that showcases his innovative approach to medical science.

Latest Patents: Sakamoto holds a patent for a medical agent aimed at suppressing arteriosclerosis. This invention involves a composition containing nicardipine or a pharmaceutically acceptable salt thereof as the effective component. This patent highlights his commitment to advancing healthcare solutions.

Career Highlights: Sakamoto is associated with Yamanouchi Pharmaceutical Company Ltd., where he has been instrumental in research and development. His work at the company has allowed him to focus on creating effective medical treatments that can improve patient outcomes.

Collaborations: One of his notable collaborators is Isao Ohata. Together, they have worked on various projects that aim to enhance the efficacy of medical treatments.

Conclusion: Nobuo Sakamoto's contributions to medical science through his innovative patent demonstrate his dedication to improving health outcomes. His work continues to influence the field and offers hope for advancements in treating arteriosclerosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…